Clinicopathological significance of deoxycytidine kinase expression in esophageal squamous cell carcinoma

Deoxycytidine kinase (dCK) mediates the rate-limiting catabolic step in the activation of gemcitabine. Gemcitabine is a key drug for pancreatic and biliary tract cancer. However, gemcitabine is not widely used for esophageal squamous cell carcinoma (ESCC). In this study, we analyzed the expression o...

Descripción completa

Detalles Bibliográficos
Autores principales: SHIMADA, YUTAKA, OKUMURA, TOMOYUKI, SEKINE, SHINICHI, MORIYAMA, MAKOTO, HOJO, SHOZO, MATSUI, KOSHI, SAWADA, SHIGEAKI, NAGATA, TAKUYA, FUKUOKA, JUNYA, TSUKADA, KAZUHIRO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915311/
https://www.ncbi.nlm.nih.gov/pubmed/24649234
http://dx.doi.org/10.3892/mco.2013.114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915311/
https://www.ncbi.nlm.nih.gov/pubmed/24649234
http://dx.doi.org/10.3892/mco.2013.114

Ejemplares similares